Cyclosporin remains the most widely used immunosuppressive agent in patients
undergoing allogeneic stem cell transplantation (SCT). The increased awareness of the …

Most experience of the therapeutic drug monitoring of immunosuppressive agents has been
acquired in the field of solid organ transplantation; however, agents such as cyclosporin …

A randomized clinical trial comparing tacrolimus with cyclosporine, both with short-course
methotrexate, as prophylaxis against graft-vs.-host disease (GVHD) in allogeneic HLA …

This single-center retrospective study analyzed 85 consecutive patients who underwent
allogeneic stem cell transplantation (allo-SCT) with the aim to assess whether there is a …

Mycophenolate mofetil is used increasingly to provide immunosuppression after
nonmyeloablative allogeneic hematopoietic cell transplantation. There is wide variability in …

To determine whether calcineurin inhibitor (CNI) blood concentrations within the first month
after allogeneic hematopoietic cell transplantation (HCT) correlated with the incidence of …

In order to determine optimal CsA trough blood concentrations (TBC) in the early post
transplantation period, we analysed relationships between TBC and acute graft-versus-host …

Objectives This retrospective study analyzed the impact of early cyclosporine A (CsA)
initiation (day− 3) on the risk of acute graft‐vs‐host disease (aGvHD) after haploidentical …

Great variations exist in the prophylaxis and treatment of GVHD in children undergoing
allogeneic stem cell transplantation (SCT). The EBMT Working Party Paediatric Diseases …

The aim of this study was to identify the risk factors for acute graft-versus-host disease
(aGVHD) in children transplanted from a matched-sibling donor (MSD) or an unrelated …